Jaime Kwok

ORCID: 0000-0003-0702-3451
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Head and Neck Cancer Studies
  • Prostate Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Diversity and Career in Medicine
  • Bladder and Urothelial Cancer Treatments
  • Dysphagia Assessment and Management
  • Advances in Oncology and Radiotherapy
  • Platelet Disorders and Treatments
  • Radiation Dose and Imaging
  • Oral health in cancer treatment
  • Genital Health and Disease
  • Meningioma and schwannoma management
  • Nail Diseases and Treatments
  • Hemophilia Treatment and Research
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Bone health and treatments
  • Childhood Cancer Survivors' Quality of Life
  • Dupuytren's Contracture and Treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Voice and Speech Disorders
  • Acute Lymphoblastic Leukemia research
  • Economic and Financial Impacts of Cancer
  • Palliative Care and End-of-Life Issues
  • Glioma Diagnosis and Treatment

University of Calgary
2020-2024

University College London
2024

Baker Hughes (Canada)
2024

Alberta Health Services
2021

University of British Columbia
2013-2018

Highlights•Current treatment planning methods constrain pharyngeal constrictor mean dose.•Literature constraints classify patient-reported dysphagia below 60% accuracy.•Decision tree and feature selection method identified new clinical constraints.•Combination mid-dose perform better than literature.AbstractAimsHead neck radiotherapy long-term survival continues to improve the management of side-effects is moving forefront patient care. Dysphagia associated with dose constrictors can be...

10.1016/j.clon.2024.01.002 article EN cc-by-nc-nd Clinical Oncology 2024-01-11

Background: There is no consensus about the best treatment for Dupuytren contracture in hand. In particular, whether to use a percutaneous needle fasciotomy (PCNF) preference limited fasciectomy (LF). Methods: We performed retrospective review of outcomes 74 joints treated with either PCNF or LF. Baseline characteristics, complications, and active extension deficit (AED) were assessed at 3 weeks months posttreatment. Reoperative procedures analyzed assess effectiveness repeated procedures....

10.1097/gox.0000000000006326 article EN cc-by-nc-nd Plastic & Reconstructive Surgery Global Open 2024-11-01

231 Background: Early biochemical detection and subsequent slow progression of recurrent prostate cancer after primary radiotherapy permit the delivery potentially curative local salvage therapy (LST). Several LST options are available, including cryotherapy, brachytherapy (BT), radical prostatectomy (RP). We studied rates at which patients offered, receive failure radiotherapy. Methods: Patients with localized who received intent between 1999-2000 were identified in British Columbia...

10.1200/jco.2013.31.6_suppl.231 article EN Journal of Clinical Oncology 2013-02-20

CARO VSM 2020 period, one out of 25 cancer cases presented with synchronous lung metastasis.Synchronous metastases most commonly arose from primary cancers, colorectal kidney pancreatic cancers and breast cancers.The proportion presenting metastasis increased over time.At a median follow-up 33 months, the survival all metastatic was five two-year overall 17.4%.De novo patients had worse (hazard ratio = 1.22 (1.21 to 1.23), p<0.001) compared those only extrapulmonary metastases, controlling...

10.1016/s0167-8140(20)31074-4 article EN cc-by-nc-nd Radiotherapy and Oncology 2020-09-01

111 Background: Local prostate radiotherapy (LPRT) is associated with improved overall survival in patients low metastatic burden (MB) and now standard of care. However, the role LPRT reducing symptomatic local events (SLE) cancer (MPC) remains unclear requires long-term follow-up. The purpose this study was two-fold: i) identify risk factors SLE, ii) evaluate association between SLE MPC. Methods: We conducted a retrospective, population-based cohort diagnosed initial MPC 2005 2016. Patients...

10.1200/jco.2021.39.6_suppl.111 article EN Journal of Clinical Oncology 2021-02-20

The study objective was to determine the representation of women in Canadian radiation oncology (RO) trainees and oncologist workforce over time.Gender data for RO (residents fellows) oncologists were collected from Post-MD Education Registry (1994-2021) Medical Association (1994-2019). Visa excluded. Gender parity defined as a 1:1 female-to-male ratio. Descriptive statistics used summarize data.Female trainee proportions varied with 2 rising trend periods (1994-1998: 38%-43%, P = .93;...

10.1016/j.adro.2022.101023 article EN cc-by-nc-nd Advances in Radiation Oncology 2022-07-14
Coming Soon ...